Nadolol

Last Updated: 02/24/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1434 publications

Different beta-blockers for preventing arrhythmic events in patients with long QT syndrome: a network meta-analysis.

Different beta-blockers for preventing arrhythmic events in patients with long QT syndrome: a network meta-analysis.

Journal: Frontiers in medicine
Published: October 23, 2025

Breastfeeding During Maternal Nadolol Therapy for Long QT Syndrome: Five-Month Infant Follow-Up.

Breastfeeding During Maternal Nadolol Therapy for Long QT Syndrome: Five-Month Infant Follow-Up.

Journal: Pediatric cardiology
Published: October 22, 2025

Comparing the Molecular Pharmacological Properties of Existing β-Blockers to Determine the Theoretically Most "Ideal" Anti-Cancer β-Blocker.

Comparing the Molecular Pharmacological Properties of Existing β-Blockers to Determine the Theoretically Most "Ideal" Anti-Cancer β-Blocker.

Journal: Pharmacology research & perspectives
Published: October 20, 2025

Exploring Nadolol as a Therapeutic Option for Infantile Hemangioma: A Narrative Review.

Exploring Nadolol as a Therapeutic Option for Infantile Hemangioma: A Narrative Review.

Journal: Cureus
Published: October 19, 2025

Fate, chlorination kinetics, and comprehensive risk assessment of pharmaceuticals and personal care products in drinking water distribution systems.

Fate, chlorination kinetics, and comprehensive risk assessment of pharmaceuticals and personal care products in drinking water distribution systems.

Journal: Journal of contaminant hydrology
Published: October 09, 2025

Compounding and stability studies of liquid oral formulations of beta-blockers (bisoprolol, betaxolol, and nadolol) for paediatric patients.

Compounding and stability studies of liquid oral formulations of beta-blockers (bisoprolol, betaxolol, and nadolol) for paediatric patients.

Journal: Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques
Published: August 05, 2025

Carvedilol is associated with lower mortality than other nonselective beta-blockers in patients with cirrhosis.

Carvedilol is associated with lower mortality than other nonselective beta-blockers in patients with cirrhosis.

Journal: Proceedings (Baylor University. Medical Center)
Published: June 25, 2025

Beta adrenergic signaling as a therapeutic target for autoimmunity.

Beta adrenergic signaling as a therapeutic target for autoimmunity.

Journal: Journal of neuroimmunology
Published: May 30, 2025

Beta Adrenergic Signaling as a Therapeutic Target for Autoimmunity.

Beta Adrenergic Signaling as a Therapeutic Target for Autoimmunity.

Journal: bioRxiv : the preprint server for biology
Published: April 28, 2025

Integrative Approaches in the Management of Hypertrophic Cardiomyopathy: A Comprehensive Review of Current Therapeutic Modalities.

Integrative Approaches in the Management of Hypertrophic Cardiomyopathy: A Comprehensive Review of Current Therapeutic Modalities.

Journal: Biomedicines
Published: April 19, 2025

Development of Chitosan-Coated Liposomes for Oral Delivery of Nadolol: Preparation, Characterization, and in vitro Permeability Studies.

Development of Chitosan-Coated Liposomes for Oral Delivery of Nadolol: Preparation, Characterization, and in vitro Permeability Studies.

Journal: Current pharmaceutical design
Published: April 13, 2025

Exploring phytochemical candidates against nephrolithiasis via similarity searching, network pharmacology, and docking studies.

Exploring phytochemical candidates against nephrolithiasis via similarity searching, network pharmacology, and docking studies.

Journal: Biochemical and biophysical research communications
Published: March 21, 2025
Showing 1-12 of 1,434

Last Updated: 02/24/2026